🇺🇸 FDA
Pipeline program

iC9.GD2.CAR.IL-15 T-cells

LCCC 1743-ATL

Phase 1 mab active

Quick answer

iC9.GD2.CAR.IL-15 T-cells for Neuroblastoma is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Neuroblastoma
Phase
Phase 1
Modality
mab
Status
active

Clinical trials